NCT06902233 Brain Network Stimulation for Chronic Low Back Pain.
| NCT ID | NCT06902233 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Otago |
| Condition | Chronic Low Back Pain (CLBP) |
| Study Type | INTERVENTIONAL |
| Enrollment | 164 participants |
| Start Date | 2025-06-12 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 164 participants in total. It began in 2025-06-12 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study looks at the non-invasive brain stimulation technique in people with chronic low back pain to see: * How effective non-invasive brain stimulation is at improving pain intensity in people with chronic low back pain? * How safe non-invasive brain stimulation is and what side effects there may be? * What study participants think of the study procedures and of the non-invasive brain stimulation as a treatment technique for chronic low back pain. Participants will be assigned to receive either active brain stimulation group or sham stimulation group randomly. Participants will be required to attend a total of twelve treatment sessions (approximately 1-hour each, three sessions per week, for four consecutive weeks). Assessments will be done at baseline (in the week 0), immediately post-completion of the intervention (in the week 5), and at the follow-up of one-month (in the week 8), three-months (in the week 16) and six-months (in the week 28) post-completion of intervention.
Eligibility Criteria
Inclusion Criteria: * Age between 18 to 75 years on the day of screening * Pain in the lower back (region between 12th rib and gluteal fold) with or without accompanying leg pain that occurs for at least half the days in the last six months * An average pain intensity of ≥4 on the 11-point NPRS (0=No pain to 10=Pain as bad as you can imagine) in the week prior to enrolment * A disability score of ≥5 on Roland-Morris Disability Questionnaire (RMDQ). Exclusion Criteria: * Known or suspected serious spinal pathology (fracture; lumbar canal stenosis, malignant, inflammatory or infective diseases of the spine; cauda equina syndrome or widespread neurological disorder) * Suspected or confirmed pregnancy or less than six months post-partum * Inflammatory disorders * Auto-immune conditions * Recent soft tissue injuries of the back in the last 3 months * Recent steroid injections to the back in the past 3 months * Recent spinal surgery in the past 12 months or scheduled/waiting for any major surgical procedures during the treatment or follow-up period or underwent rhizotomy or any neurosurgical procedures * History of neurological conditions, or psychiatric disorders (except depression and anxiety disorders) * History of cancer, or currently receiving/scheduled for receiving therapy for cancer * Cognitive impairments (dementia, Alzheimer's disease; indicated by a total score of 24 or below on Mini-Mental State Examination) * Alcohol or substance abuse * History of epilepsy or seizures * Presence of any electronic implants (e.g., pacemaker), metal implant in the body (particularly head and neck), or spinal cord stimulator.
Contact & Investigator
Divya Adhia, Ph.D
PRINCIPAL INVESTIGATOR
Department of Surgical Sciences, Dunedin School Of Medicine, University of Otago, Dunedin, New Zealand.
Frequently Asked Questions
Who can join the NCT06902233 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Chronic Low Back Pain (CLBP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06902233 currently recruiting?
Yes, NCT06902233 is actively recruiting participants. Contact the research team at divya.adhia@otago.ac.nz for enrollment information.
Where is the NCT06902233 trial being conducted?
This trial is being conducted at Dunedin, New Zealand.
Who is sponsoring the NCT06902233 clinical trial?
NCT06902233 is sponsored by University of Otago. The principal investigator is Divya Adhia, Ph.D at Department of Surgical Sciences, Dunedin School Of Medicine, University of Otago, Dunedin, New Zealand.. The trial plans to enroll 164 participants.